Pulse Biosciences Inc (NAS:PLSE)

$ 18.02 -0.71 (-3.79%) Market Cap: 1.11 Bil Enterprise Value: 1.08 Bil PE Ratio: 0 PB Ratio: 14.01 GF Score: 40/100

Q3 2024 Pulse Biosciences Inc Earnings Call Transcript
Oct 30, 2024

$17.72 (+3.99%)

Earnings
Q2 2024 Pulse Biosciences Inc Earnings Call Transcript
Aug 12, 2024

$15.65

Earnings
Q1 2024 Pulse Biosciences Inc Earnings Call Transcript
May 07, 2024

$7.47 (-1.68%)

Earnings
Q4 2023 Pulse Biosciences Inc Earnings Call Transcript
Mar 28, 2024

$8.56 (+3.69%)

Earnings
Pulse Biosciences Inc Extraordinary Shareholders Meeting Transcript
Dec 19, 2023
Q3 2023 Pulse Biosciences Inc Earnings Call Transcript
Nov 13, 2023

$5.32 (+4.84%)

Earnings
Q2 2023 Pulse Biosciences Inc Earnings Call Transcript
Aug 10, 2023

$6.73 (-5.66%)

Earnings
Q1 2023 Pulse Biosciences Inc Earnings Call Transcript
May 11, 2023

$7.48 (-8.31%)

Earnings
Q4 2022 Pulse Biosciences Inc Earnings Call Transcript
Mar 30, 2023

$2.44 (-1.20%)

Earnings
Q3 2022 Pulse Biosciences Inc Earnings Call Transcript
Nov 10, 2022

$2.05 (+13.04%)

Earnings
Q2 2022 Pulse Biosciences Inc Earnings Call Transcript
Aug 10, 2022

$1.68 (+6.87%)

Earnings
Q1 2022 Pulse Biosciences Inc Earnings Call Transcript
May 11, 2022

$1.9 (-17.17%)

Earnings
Q4 2021 Pulse Biosciences Inc Earnings Call Transcript
Mar 31, 2022

$4.78 (-2.02%)

Earnings
Q3 2021 Pulse Biosciences Inc Earnings Call Transcript
Nov 15, 2021

$21.32 (+0.23%)

Earnings
Q2 2021 Pulse Biosciences Inc Earnings Call Transcript
Aug 09, 2021

$22.23 (-1.27%)

Earnings
Pulse Biosciences Inc Annual Shareholders Meeting Transcript
May 20, 2021
Q1 2021 Pulse Biosciences Inc Earnings Call Transcript
May 10, 2021

$16.04 (-4.90%)

Earnings
Q4 2020 Pulse Biosciences Inc Earnings Call Transcript
Feb 22, 2021

$33.88 (-2.85%)

Earnings
Q3 2020 Pulse Biosciences Inc Earnings Call Transcript
Nov 09, 2020

$11.69 (-2.14%)

Earnings
Q2 2020 Pulse Biosciences Inc Earnings Call Transcript
Aug 10, 2020

$10.41 (-4.85%)

Earnings
Pulse Biosciences Inc Annual Shareholders Meeting Transcript
May 14, 2020
Q1 2020 Pulse Biosciences Inc Earnings Call Transcript
May 11, 2020

$11.54 (+6.53%)

Earnings
Q4 2019 Pulse Biosciences Inc Earnings Call Transcript
Mar 16, 2020

$5.14 (-9.36%)

Earnings
Pulse Biosciences, Inc. - Special Call Transcript
Feb 18, 2020
Q3 2019 Pulse Biosciences Inc Earnings Call Transcript
Nov 07, 2019

$14.07 (-4.02%)

Earnings
Q2 2019 Pulse Biosciences Inc Earnings Call Transcript
Aug 08, 2019

$11.34 (+4.53%)

Earnings
Q1 2019 Pulse Biosciences Inc Earnings Call Transcript
Apr 30, 2019

$15.75 (-5.15%)

Earnings

Pulse Biosciences Inc Extraordinary Shareholders Meeting Transcript

Dec 19, 2023 / 07:30PM GMT

Release Date Price: $12.17 (+26.97%)

Transcript

Operator

Good morning. And welcome to the 2023 special meeting of stockholders of Pulse Biosciences, Inc. I would now like to introduce the first presenter, Mr. Kevin P. Danahy, Chief Executive Officer of Pulse Biosciences.

Kevin Danahy Pulse Biosciences

Inc. - President & CEO

Good morning, ladies and gentlemen. I am Kevin Danahy, President and Chief Executive Officer of Pulse Biosciences. And as Chairperson for this meeting, it is my pleasure to welcome you to the special meeting of our stockholders. I've asked Ken Stratton, our General Counsel and Corporate Secretary, to act as Secretary for this meeting and record the minutes.

Given the limited agenda for this meeting and because of the holiday season is busy for everyone, including the team here at Pulse Bio, back in November, we decided to hold this meeting virtually. And we are glad that you are able to join us today.

Before proceeding further, please let me introduce the company's directors who are in attendance today and on the line: Robert Duggan, our Chief Executive Chairman; Darrin

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.